Study ID: LA-LAQ-202
Study Title
- Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Arthritis
Teva Identifier
- LA-LAQ-202
ClinicalTrials.gov Identifier
- NCT01085084
Study Status
- Completed
Trial Condition(s)
- Lupus Arthritis
Interventions
- Drug: Laquinimod | Other: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 75 Years
Trial Duration
- 07/01/2010 - 10/01/2012
Phase
- Phase 2
Study Type
Interventional